Outset Medical, Inc. (NASDAQ:OM) Shares Sold by Fmr LLC

Fmr LLC trimmed its holdings in shares of Outset Medical, Inc. (NASDAQ:OM) by 38.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,773,776 shares of the company’s stock after selling 2,923,144 shares during the period. Fmr LLC owned approximately 9.09% of Outset Medical worth $3,232,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Assenagon Asset Management S.A. grew its holdings in Outset Medical by 60.4% during the second quarter. Assenagon Asset Management S.A. now owns 1,515,126 shares of the company’s stock worth $5,833,000 after acquiring an additional 570,281 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in Outset Medical by 75.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 82,636 shares of the company’s stock worth $184,000 after acquiring an additional 35,495 shares during the period. Acadian Asset Management LLC grew its holdings in Outset Medical by 5.2% during the second quarter. Acadian Asset Management LLC now owns 819,563 shares of the company’s stock worth $3,154,000 after acquiring an additional 40,321 shares during the period. Los Angeles Capital Management LLC acquired a new position in shares of Outset Medical in the 2nd quarter valued at $731,000. Finally, Huntington National Bank boosted its position in shares of Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the period.

Outset Medical Trading Down 8.3 %

NASDAQ:OM opened at $1.11 on Friday. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 1-year low of $0.44 and a 1-year high of $6.37. The firm has a market capitalization of $58.32 million, a price-to-earnings ratio of -0.40 and a beta of 2.16. The stock has a fifty day simple moving average of $0.79 and a 200 day simple moving average of $1.87.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.